Cargando…
Retraction Note to: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells
Autores principales: | Hu, Yang, Xie, Hong, Liu, Yankun, Liu, Weiying, Liu, Min, Tang, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108323/ https://www.ncbi.nlm.nih.gov/pubmed/33971879 http://dx.doi.org/10.1186/s12935-021-01958-0 |
Ejemplares similares
-
Correction to: RETRACTED ARTICLE: miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells
por: Hu, Yang, et al.
Publicado: (2020) -
miR-484 suppresses proliferation and epithelial–mesenchymal transition by targeting ZEB1 and SMAD2 in cervical cancer cells
por: Hu, Yang, et al.
Publicado: (2017) -
Retraction Note: Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells
por: Feng, Shuang, et al.
Publicado: (2023) -
Retraction Note: A novel microRNA identified in hepatocellular carcinomas is responsive to LEF1 and facilitates proliferation and epithelial-mesenchymal transition via targeting of NFIX
por: Hu, Yaqi, et al.
Publicado: (2021) -
Retraction Note: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2
por: Li, Chen, et al.
Publicado: (2023)